[ad_1]
The Women and Lung Cancer Research and Preventive Service Act Will Expand Resources to Understand the Science of Lung Cancer in Women
SAN CARLOS, Calif. and WASHINGTON, July 12, 2023 /PRNewswire/ — Today, GO2 for Lung Cancer (GO2) applauded the efforts of a bipartisan and bicameral group of lawmakers to address the public health imperative affecting women impacted by lung cancer – the leading cause of cancer death among women.
The Women and Lung Cancer Research and Preventive Services Act of 2023, introduced in both the House of Representatives by Congressmen Brendan Boyle (D-PA) and Brian Fitzpatrick (R-PA) and in the Senate by Senators Marco Rubio (R-FL) and Dianne Feinstein (D-CA), would increase research focus on lung cancer’s unique impact on women. The legislation would also help improve access to lung cancer screening services and elevate national awareness on the disease. Lung cancer kills more women than any other type of cancer, yet it receives the least amount of federal research funding. Every day, nearly 200 American women die of the disease.
“The time is now to transform survivorship for women impacted by lung cancer,” said Laurie Fenton Ambrose, President & CEO of GO2. “This has been a core priority of ours for years and we are grateful to these elected leaders who are accelerating lifesaving change for our community.”
“Lung cancer develops differently in women and men,” continued Fenton Ambrose. “There are sex differences in many facets of the disease, including risk factors, clinical characteristics, progression and length of survival. Yet research on these differences is far from conclusive – and woefully lacking. The result has limited opportunities to improve preventive, diagnostic and therapeutic practices. Increasing the investment in women’s health research will reverse this this trend.”
The legislation directs the Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs,…
[ad_2]
